LARSON MATTHEW PAUL 4

4 · Slide Insurance Holdings, Inc. · Filed Mar 5, 2026

Form 4

Period: 2026-03-03

Chief Risk Officer

Transactions

Sale
Common Stock
[F1]
2026-03-03$19.01/sh−11,250$213,863→ 0 total
Exercise/Conversion
Common Stock
2026-03-03$0.79/sh+11,250$8,888→ 11,250 total
Exercise/Conversion
Stock Option (Right to Buy)
[F2][F3]
2026-03-03−11,250→ 76,250 total
Exercise: $0.79Exp: 2032-02-21→ Common Stock (11,250 underlying)

Holdings

Stock Option (Right to Buy)
[F2][F3]
Exercise: $0.79Exp: 2032-02-24→ Common Stock (110,000 underlying)
110,000
Stock Option (Right to Buy)
[F2][F4]
Exercise: $1.38Exp: 2033-07-12→ Common Stock (55,000 underlying)
55,000

Footnotes (4)

[F1]Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $19.00 to $19.04 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
[F2]The exercise price, expiration date and number of stock options reported herein differ from those previously reported on the Reporting Person's Form 3 due to an administrative error. This Form 4 reflects the correct exercise price, expiration date and number of stock options held as of such date.
[F3]These stock options are fully vested and exercisable.
[F4]Of the 55,000 stock options reported herein, 27,500 are vested and exercisable. The remaining 27,500 vest ratably on July 14, 2026 and July 14, 2027.

Signature

/s/ Anastasios Omiridis, Attorney-in-Fact for Matthew Larson|2026-03-05

Documents

1 file